Group One Trading
ARIA

Group One Trading’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Group One Trading’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-440,200
Closed -$5.48M – 5386
2016
Q4 		$5.48M Sell
440,200
-439,200
-50% -$5.29M 0.05% 407
2016
Q3 		$12M Buy
879,400
+140,600
+19% +$1.41M 0.13% 151
2016
Q2 		$5.46M Buy
738,800
+392,700
+113% +$2.95M 0.06% 357
2016
Q1 		$2.21M Sell
346,100
-265,400
-43% -$1.49M 0.03% 714
2015
Q4 		$3.82M Buy
611,500
+142,400
+30% +$935K 0.05% 490
2015
Q3 		$2.74M Sell
469,100
-267,000
-36% -$2.06M 0.04% 612
2015
Q2 		$6.09M Buy
736,100
+489,600
+199% +$4.33M 0.09% 251
2015
Q1 		$2.03M Sell
246,500
-1,215,100
-83% -$8.98M 0.03% 628
2014
Q4 		$10M Buy
1,461,600
+280,700
+24% +$1.76M 0.15% 118
2014
Q3 		$6.38M Sell
1,180,900
-180,600
-13% -$1.05M 0.1% 219
2014
Q2 		$8.67M Sell
1,361,500
-534,400
-28% -$3.68M 0.13% 146
2014
Q1 		$15.3M Buy
1,895,900
+441,300
+30% +$3.44M 0.26% 56
2013
Q4 		$9.92M Buy
1,454,600
+1,325,000
+1,022% +$7.15M 0.15% 111
2013
Q3 		$2.38M Sell
129,600
-6,600
-5% -$128K 0.05% 469
2013
Q2 		$2.38M Buy
+136,200
New +$2.41M 0.06% 336

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Group One Trading's ARIA Position: Q2 2016 in Review

Group One Trading sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2016, closing a stake of 48,395 shares — an estimated $363K sold.

Group One Trading first reported a position in ARIA in Q2 2013 and held it in 12 quarters. The position peaked at $6.67M in Q4 2013. 182 funds tracked by Wall St. Rank hold ARIA as of Q2 2016.

  • Group One Trading reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Group One Trading sold 48,395 Ariad Pharmaceuticals Inc shares in Q2 2016, an estimated $363K.
  • Group One Trading first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Group One Trading's Ariad Pharmaceuticals Inc position peaked at $6.67M in Q4 2013.
  • 182 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2016.

Based on Group One Trading's 13F filing for Q2 2016, filed 12 Aug 2016.